Additionally, SLC9A6‐126aa expression was positively correlated with increased CD36 mRNA and p‐p38 and p‐ERK levels in the livers of NAFLD patients. The gene discussed is SLC9A6; the disease is metabolic dysfunction-associated steatotic liver disease.